PDB Short entry for 2GQN HEADER LYASE 21-APR-06 2GQN TITLE CYSTATHIONINE BETA-LYASE (CBL) FROM ESCHERICHIA COLI IN COMPLEX WITH TITLE 2 N-HYDRAZINOCARBONYLMETHYL-2-NITRO-BENZAMIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CYSTATHIONINE BETA-LYASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: CBL, BETA-CYSTATHIONASE, CYSTEINE LYASE; COMPND 5 EC: 4.4.1.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 562; SOURCE 4 GENE: METC; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS PROTEIN-INHIBITOR COMPLEX, PLP COFACTOR COVALENTLY BOUNT TO BLP KEYWDS 2 INHIBITOR, LYASE EXPDTA X-RAY DIFFRACTION AUTHOR R.SUMMERFIELD,M.S.JUNOP REVDAT 4 14-FEB-24 2GQN 1 REMARK SEQADV REVDAT 3 13-JUL-11 2GQN 1 VERSN REVDAT 2 24-FEB-09 2GQN 1 VERSN REVDAT 1 06-MAR-07 2GQN 0 JRNL AUTH L.J.EJIM,J.E.BLANCHARD,K.P.KOTEVA,R.SUMERFIELD,N.H.ELOWE, JRNL AUTH 2 J.D.CHECHETTO,E.D.BROWN,M.S.JUNOP,G.D.WRIGHT JRNL TITL INHIBITORS OF BACTERIAL CYSTATHIONINE BETA-LYASE: LEADS FOR JRNL TITL 2 NEW ANTIMICROBIAL AGENTS AND PROBES OF ENZYME STRUCTURE AND JRNL TITL 3 FUNCTION. JRNL REF J.MED.CHEM. V. 50 755 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17300162 JRNL DOI 10.1021/JM061132R REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 60975 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.177 REMARK 3 R VALUE (WORKING SET) : 0.174 REMARK 3 FREE R VALUE : 0.227 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 3250 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 4377 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.79 REMARK 3 BIN R VALUE (WORKING SET) : 0.3070 REMARK 3 BIN FREE R VALUE SET COUNT : 230 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 6033 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 64 REMARK 3 SOLVENT ATOMS : 947 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 18.69 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 4.03000 REMARK 3 B22 (A**2) : -1.95000 REMARK 3 B33 (A**2) : -2.08000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.148 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.141 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.087 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 6.737 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.969 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 6225 ; 0.018 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 8445 ; 1.739 ; 1.956 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 781 ; 6.299 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 272 ;38.084 ;23.971 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1020 ;14.677 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 36 ;24.384 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 947 ; 0.116 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 4724 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 3313 ; 0.217 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4278 ; 0.312 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 724 ; 0.171 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 206 ; 0.260 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 90 ; 0.201 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3977 ; 1.137 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 6214 ; 1.400 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2561 ; 2.745 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 2231 ; 3.933 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2GQN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 28-APR-06. REMARK 100 THE DEPOSITION ID IS D_1000037435. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 27-AUG-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.3 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RU300 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : OSMIC MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 DATA SCALING SOFTWARE : D*TREK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 64262 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7 REMARK 200 DATA REDUNDANCY : 6.770 REMARK 200 R MERGE (I) : 0.07800 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 11.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.86 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.30300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 35.19 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.90 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES, 0.15M CALCIUM CHLORIDE, REMARK 280 AND 26% PEG400, PH 7.3, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 75.62000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 75.62000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 29.81850 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 76.50350 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 29.81850 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 76.50350 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 75.62000 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 29.81850 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 76.50350 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 75.62000 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 29.81850 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 76.50350 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSMEBLY IS A TETRAMER GENERATED FROM THE REMARK 300 DIMER IN THE ASYMMETRIC UNIT BY THE OPERATION -X,Y,1/2-Z. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 22540 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 44340 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -77.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 75.62000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 735 LIES ON A SPECIAL POSITION. REMARK 375 HOH A 947 LIES ON A SPECIAL POSITION. REMARK 375 HOH B 774 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ASP A 3 REMARK 465 LYS A 4 REMARK 465 MET B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 ASP B 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 363 CG GLU A 363 CD 0.090 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG B 285 NE - CZ - NH2 ANGL. DEV. = -3.9 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 15 50.49 -91.21 REMARK 500 SER A 32 -76.31 -97.02 REMARK 500 PHE A 55 -53.53 -138.59 REMARK 500 ILE A 159 -60.52 78.28 REMARK 500 LYS A 210 -111.34 -74.02 REMARK 500 ILE A 220 139.16 -173.48 REMARK 500 SER A 308 -154.66 -100.98 REMARK 500 SER A 339 -177.59 68.88 REMARK 500 TRP A 340 -176.65 -177.65 REMARK 500 GLN A 361 19.55 58.91 REMARK 500 ARG B 15 49.06 -93.66 REMARK 500 SER B 32 -74.74 -103.75 REMARK 500 PHE B 55 -54.09 -135.62 REMARK 500 THR B 61 -167.90 -117.80 REMARK 500 TYR B 111 130.02 -39.31 REMARK 500 ILE B 159 -59.93 75.86 REMARK 500 THR B 209 -35.71 -37.00 REMARK 500 LYS B 210 -112.57 -79.83 REMARK 500 ILE B 220 141.40 -176.09 REMARK 500 ASN B 287 78.59 -101.92 REMARK 500 SER B 308 -159.58 -99.01 REMARK 500 SER B 339 -179.54 60.58 REMARK 500 TRP B 340 177.99 176.89 REMARK 500 ARG B 359 73.52 -116.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA A 31 SER A 32 149.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLP A 700 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BLP B 700 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2FQ6 RELATED DB: PDB REMARK 900 SAME PROTEIN COMPLEXED WITH N-HYDRAZINOCARBONYLMETHYL-2- REMARK 900 TRIFLUOROMETHYL-BENZAMIDE DBREF 2GQN A 1 395 UNP P06721 METC_ECOLI 1 395 DBREF 2GQN B 1 395 UNP P06721 METC_ECOLI 1 395 SEQADV 2GQN MET A -19 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY A -18 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER A -17 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER A -16 UNP P06721 CLONING ARTIFACT SEQADV 2GQN HIS A -15 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS A -14 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS A -13 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS A -12 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS A -11 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS A -10 UNP P06721 EXPRESSION TAG SEQADV 2GQN SER A -9 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER A -8 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY A -7 UNP P06721 CLONING ARTIFACT SEQADV 2GQN LEU A -6 UNP P06721 CLONING ARTIFACT SEQADV 2GQN VAL A -5 UNP P06721 CLONING ARTIFACT SEQADV 2GQN PRO A -4 UNP P06721 CLONING ARTIFACT SEQADV 2GQN ARG A -3 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY A -2 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER A -1 UNP P06721 CLONING ARTIFACT SEQADV 2GQN HIS A 0 UNP P06721 CLONING ARTIFACT SEQADV 2GQN MET B -19 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY B -18 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER B -17 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER B -16 UNP P06721 CLONING ARTIFACT SEQADV 2GQN HIS B -15 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS B -14 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS B -13 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS B -12 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS B -11 UNP P06721 EXPRESSION TAG SEQADV 2GQN HIS B -10 UNP P06721 EXPRESSION TAG SEQADV 2GQN SER B -9 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER B -8 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY B -7 UNP P06721 CLONING ARTIFACT SEQADV 2GQN LEU B -6 UNP P06721 CLONING ARTIFACT SEQADV 2GQN VAL B -5 UNP P06721 CLONING ARTIFACT SEQADV 2GQN PRO B -4 UNP P06721 CLONING ARTIFACT SEQADV 2GQN ARG B -3 UNP P06721 CLONING ARTIFACT SEQADV 2GQN GLY B -2 UNP P06721 CLONING ARTIFACT SEQADV 2GQN SER B -1 UNP P06721 CLONING ARTIFACT SEQADV 2GQN HIS B 0 UNP P06721 CLONING ARTIFACT SEQRES 1 A 415 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 415 LEU VAL PRO ARG GLY SER HIS MET ALA ASP LYS LYS LEU SEQRES 3 A 415 ASP THR GLN LEU VAL ASN ALA GLY ARG SER LYS LYS TYR SEQRES 4 A 415 THR LEU GLY ALA VAL ASN SER VAL ILE GLN ARG ALA SER SEQRES 5 A 415 SER LEU VAL PHE ASP SER VAL GLU ALA LYS LYS HIS ALA SEQRES 6 A 415 THR ARG ASN ARG ALA ASN GLY GLU LEU PHE TYR GLY ARG SEQRES 7 A 415 ARG GLY THR LEU THR HIS PHE SER LEU GLN GLN ALA MET SEQRES 8 A 415 CYS GLU LEU GLU GLY GLY ALA GLY CYS VAL LEU PHE PRO SEQRES 9 A 415 CYS GLY ALA ALA ALA VAL ALA ASN SER ILE LEU ALA PHE SEQRES 10 A 415 ILE GLU GLN GLY ASP HIS VAL LEU MET THR ASN THR ALA SEQRES 11 A 415 TYR GLU PRO SER GLN ASP PHE CYS SER LYS ILE LEU SER SEQRES 12 A 415 LYS LEU GLY VAL THR THR SER TRP PHE ASP PRO LEU ILE SEQRES 13 A 415 GLY ALA ASP ILE VAL LYS HIS LEU GLN PRO ASN THR LYS SEQRES 14 A 415 ILE VAL PHE LEU GLU SER PRO GLY SER ILE THR MET GLU SEQRES 15 A 415 VAL HIS ASP VAL PRO ALA ILE VAL ALA ALA VAL ARG SER SEQRES 16 A 415 VAL VAL PRO ASP ALA ILE ILE MET ILE ASP ASN THR TRP SEQRES 17 A 415 ALA ALA GLY VAL LEU PHE LYS ALA LEU ASP PHE GLY ILE SEQRES 18 A 415 ASP VAL SER ILE GLN ALA ALA THR LYS TYR LEU VAL GLY SEQRES 19 A 415 HIS SER ASP ALA MET ILE GLY THR ALA VAL CYS ASN ALA SEQRES 20 A 415 ARG CYS TRP GLU GLN LEU ARG GLU ASN ALA TYR LEU MET SEQRES 21 A 415 GLY GLN MET VAL ASP ALA ASP THR ALA TYR ILE THR SER SEQRES 22 A 415 ARG GLY LEU ARG THR LEU GLY VAL ARG LEU ARG GLN HIS SEQRES 23 A 415 HIS GLU SER SER LEU LYS VAL ALA GLU TRP LEU ALA GLU SEQRES 24 A 415 HIS PRO GLN VAL ALA ARG VAL ASN HIS PRO ALA LEU PRO SEQRES 25 A 415 GLY SER LYS GLY HIS GLU PHE TRP LYS ARG ASP PHE THR SEQRES 26 A 415 GLY SER SER GLY LEU PHE SER PHE VAL LEU LYS LYS LYS SEQRES 27 A 415 LEU ASN ASN GLU GLU LEU ALA ASN TYR LEU ASP ASN PHE SEQRES 28 A 415 SER LEU PHE SER MET ALA TYR SER TRP GLY GLY TYR GLU SEQRES 29 A 415 SER LEU ILE LEU ALA ASN GLN PRO GLU HIS ILE ALA ALA SEQRES 30 A 415 ILE ARG PRO GLN GLY GLU ILE ASP PHE SER GLY THR LEU SEQRES 31 A 415 ILE ARG LEU HIS ILE GLY LEU GLU ASP VAL ASP ASP LEU SEQRES 32 A 415 ILE ALA ASP LEU ASP ALA GLY PHE ALA ARG ILE VAL SEQRES 1 B 415 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 415 LEU VAL PRO ARG GLY SER HIS MET ALA ASP LYS LYS LEU SEQRES 3 B 415 ASP THR GLN LEU VAL ASN ALA GLY ARG SER LYS LYS TYR SEQRES 4 B 415 THR LEU GLY ALA VAL ASN SER VAL ILE GLN ARG ALA SER SEQRES 5 B 415 SER LEU VAL PHE ASP SER VAL GLU ALA LYS LYS HIS ALA SEQRES 6 B 415 THR ARG ASN ARG ALA ASN GLY GLU LEU PHE TYR GLY ARG SEQRES 7 B 415 ARG GLY THR LEU THR HIS PHE SER LEU GLN GLN ALA MET SEQRES 8 B 415 CYS GLU LEU GLU GLY GLY ALA GLY CYS VAL LEU PHE PRO SEQRES 9 B 415 CYS GLY ALA ALA ALA VAL ALA ASN SER ILE LEU ALA PHE SEQRES 10 B 415 ILE GLU GLN GLY ASP HIS VAL LEU MET THR ASN THR ALA SEQRES 11 B 415 TYR GLU PRO SER GLN ASP PHE CYS SER LYS ILE LEU SER SEQRES 12 B 415 LYS LEU GLY VAL THR THR SER TRP PHE ASP PRO LEU ILE SEQRES 13 B 415 GLY ALA ASP ILE VAL LYS HIS LEU GLN PRO ASN THR LYS SEQRES 14 B 415 ILE VAL PHE LEU GLU SER PRO GLY SER ILE THR MET GLU SEQRES 15 B 415 VAL HIS ASP VAL PRO ALA ILE VAL ALA ALA VAL ARG SER SEQRES 16 B 415 VAL VAL PRO ASP ALA ILE ILE MET ILE ASP ASN THR TRP SEQRES 17 B 415 ALA ALA GLY VAL LEU PHE LYS ALA LEU ASP PHE GLY ILE SEQRES 18 B 415 ASP VAL SER ILE GLN ALA ALA THR LYS TYR LEU VAL GLY SEQRES 19 B 415 HIS SER ASP ALA MET ILE GLY THR ALA VAL CYS ASN ALA SEQRES 20 B 415 ARG CYS TRP GLU GLN LEU ARG GLU ASN ALA TYR LEU MET SEQRES 21 B 415 GLY GLN MET VAL ASP ALA ASP THR ALA TYR ILE THR SER SEQRES 22 B 415 ARG GLY LEU ARG THR LEU GLY VAL ARG LEU ARG GLN HIS SEQRES 23 B 415 HIS GLU SER SER LEU LYS VAL ALA GLU TRP LEU ALA GLU SEQRES 24 B 415 HIS PRO GLN VAL ALA ARG VAL ASN HIS PRO ALA LEU PRO SEQRES 25 B 415 GLY SER LYS GLY HIS GLU PHE TRP LYS ARG ASP PHE THR SEQRES 26 B 415 GLY SER SER GLY LEU PHE SER PHE VAL LEU LYS LYS LYS SEQRES 27 B 415 LEU ASN ASN GLU GLU LEU ALA ASN TYR LEU ASP ASN PHE SEQRES 28 B 415 SER LEU PHE SER MET ALA TYR SER TRP GLY GLY TYR GLU SEQRES 29 B 415 SER LEU ILE LEU ALA ASN GLN PRO GLU HIS ILE ALA ALA SEQRES 30 B 415 ILE ARG PRO GLN GLY GLU ILE ASP PHE SER GLY THR LEU SEQRES 31 B 415 ILE ARG LEU HIS ILE GLY LEU GLU ASP VAL ASP ASP LEU SEQRES 32 B 415 ILE ALA ASP LEU ASP ALA GLY PHE ALA ARG ILE VAL HET BLP A 700 32 HET BLP B 700 32 HETNAM BLP (5-HYDROXY-6-METHYL-4-((2-(2-(2-NITROBENZAMIDO)ACETYL) HETNAM 2 BLP HYDRAZINYL)METHYL)PYRIDIN-3-YL)METHYL DIHYDROGEN HETNAM 3 BLP PHOSPHATE FORMUL 3 BLP 2(C17 H20 N5 O9 P) FORMUL 5 HOH *947(H2 O) HELIX 1 1 LYS A 5 ALA A 13 1 9 HELIX 2 2 SER A 16 LEU A 21 1 6 HELIX 3 3 SER A 38 ASN A 48 1 11 HELIX 4 4 THR A 61 GLY A 76 1 16 HELIX 5 5 CYS A 85 ALA A 96 1 12 HELIX 6 6 TYR A 111 ILE A 121 1 11 HELIX 7 7 LEU A 122 GLY A 126 5 5 HELIX 8 8 ILE A 136 LEU A 144 5 9 HELIX 9 9 ASP A 165 VAL A 177 1 13 HELIX 10 10 LYS A 195 GLY A 200 5 6 HELIX 11 11 ASN A 226 MET A 240 1 15 HELIX 12 12 ASP A 245 ARG A 257 1 13 HELIX 13 13 THR A 258 GLU A 279 1 22 HELIX 14 14 GLY A 296 PHE A 304 1 9 HELIX 15 15 ASN A 320 ASP A 329 1 10 HELIX 16 16 GLN A 351 ALA A 357 1 7 HELIX 17 17 ASP A 379 ARG A 393 1 15 HELIX 18 18 LYS B 5 ALA B 13 1 9 HELIX 19 19 SER B 16 LEU B 21 1 6 HELIX 20 20 SER B 38 ASN B 48 1 11 HELIX 21 21 TYR B 56 GLY B 60 5 5 HELIX 22 22 THR B 61 GLY B 76 1 16 HELIX 23 23 CYS B 85 ILE B 98 1 14 HELIX 24 24 TYR B 111 ILE B 121 1 11 HELIX 25 25 LEU B 122 GLY B 126 5 5 HELIX 26 26 ILE B 136 LEU B 144 5 9 HELIX 27 27 ASP B 165 VAL B 177 1 13 HELIX 28 28 LYS B 195 GLY B 200 5 6 HELIX 29 29 ASN B 226 MET B 240 1 15 HELIX 30 30 ASP B 245 ARG B 257 1 13 HELIX 31 31 THR B 258 HIS B 280 1 23 HELIX 32 32 GLY B 296 PHE B 304 1 9 HELIX 33 33 ASN B 320 ASP B 329 1 10 HELIX 34 34 GLN B 351 ALA B 357 1 7 HELIX 35 35 ASP B 379 ILE B 394 1 16 SHEET 1 A 7 GLY A 79 PHE A 83 0 SHEET 2 A 7 GLY A 221 CYS A 225 -1 O CYS A 225 N GLY A 79 SHEET 3 A 7 VAL A 203 ALA A 207 -1 N SER A 204 O VAL A 224 SHEET 4 A 7 ILE A 181 ASP A 185 1 N ILE A 184 O ILE A 205 SHEET 5 A 7 THR A 148 GLU A 154 1 N LEU A 153 O MET A 183 SHEET 6 A 7 HIS A 103 THR A 107 1 N LEU A 105 O PHE A 152 SHEET 7 A 7 THR A 128 PHE A 132 1 O THR A 128 N VAL A 104 SHEET 1 B 5 VAL A 283 ASN A 287 0 SHEET 2 B 5 LEU A 310 LEU A 315 -1 O VAL A 314 N ALA A 284 SHEET 3 B 5 LEU A 370 HIS A 374 -1 O ILE A 371 N PHE A 313 SHEET 4 B 5 LEU A 346 ASN A 350 -1 N LEU A 348 O ARG A 372 SHEET 5 B 5 SER A 335 MET A 336 1 N SER A 335 O ILE A 347 SHEET 1 C 7 GLY B 79 PHE B 83 0 SHEET 2 C 7 GLY B 221 CYS B 225 -1 O ALA B 223 N VAL B 81 SHEET 3 C 7 VAL B 203 ALA B 207 -1 N SER B 204 O VAL B 224 SHEET 4 C 7 ILE B 181 ASP B 185 1 N ILE B 184 O ILE B 205 SHEET 5 C 7 THR B 148 GLU B 154 1 N LYS B 149 O ILE B 181 SHEET 6 C 7 HIS B 103 THR B 107 1 N LEU B 105 O PHE B 152 SHEET 7 C 7 THR B 128 PHE B 132 1 O THR B 128 N VAL B 104 SHEET 1 D 5 VAL B 283 ASN B 287 0 SHEET 2 D 5 LEU B 310 LEU B 315 -1 O SER B 312 N ASN B 287 SHEET 3 D 5 LEU B 370 HIS B 374 -1 O ILE B 371 N PHE B 313 SHEET 4 D 5 LEU B 346 ASN B 350 -1 N ASN B 350 O LEU B 370 SHEET 5 D 5 SER B 335 MET B 336 1 N SER B 335 O ILE B 347 CISPEP 1 SER A 155 PRO A 156 0 -5.33 CISPEP 2 SER B 155 PRO B 156 0 -8.66 SITE 1 AC1 21 PHE A 55 TYR A 56 ARG A 58 CYS A 85 SITE 2 AC1 21 GLY A 86 ALA A 87 TYR A 111 GLU A 112 SITE 3 AC1 21 GLU A 154 ASP A 185 ALA A 207 THR A 209 SITE 4 AC1 21 LYS A 210 MET A 219 TYR A 338 SER A 339 SITE 5 AC1 21 TRP A 340 ARG A 372 HOH A 873 HOH A1134 SITE 6 AC1 21 HOH A1153 SITE 1 AC2 21 TYR B 56 ARG B 58 CYS B 85 GLY B 86 SITE 2 AC2 21 ALA B 87 TYR B 111 PRO B 113 GLU B 154 SITE 3 AC2 21 ASP B 185 ALA B 207 THR B 209 LYS B 210 SITE 4 AC2 21 MET B 219 TYR B 238 TYR B 338 SER B 339 SITE 5 AC2 21 TRP B 340 ARG B 372 HOH B 725 HOH B 742 SITE 6 AC2 21 HOH B 870 CRYST1 59.637 153.007 151.240 90.00 90.00 90.00 C 2 2 21 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016768 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006536 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006612 0.00000